1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Spherix Inc. Reports Operating Results (10-Q)

August 13, 2010 | About:

Spherix Inc. (NASDAQ:SPEX) filed Quarterly Report for the period ended 2010-06-30.

Spherix Inc. has a market cap of $25.6 million; its shares were traded at around $1.5001 with and P/S ratio of 19. Spherix Inc. had an annual average earning growth of 83.7% over the past 5 years.SPEX is in the portfolios of Jim Simons of Renaissance Technologies LLC.

Highlight of Business Operations:

Our selling, general and administrative (S,G&A) expenses consist primarily of salaries and related expenses for executive, finance and other administrative personnel, professional fees and other corporate expenses, including facilities-related expenses. S,G&A expenses for the three and six months ended June 30, 2010 increased $541,000 (83%) and $832,000 (59%) over those of the prior year. The increase in S,G&A costs between 2010 and 2009 are primarily related to the expansion of the Companys commercialization efforts of D-tagatose as a treatment for Type 2 diabetes and high-triglycerides.

As of June 30, 2010, the Company had cash and short-term investments of approximately $4.7 million and expects to expend all of this amount within the next six months. Our working capital was $3.0 million as of June 30, 2010, compared to working capital of $7.7 million as of December 31, 2009. We have incurred substantial development costs in our efforts to explore whether D-tagatose is an effective treatment for Type 2 diabetes. We have financed our development activities through the remaining proceeds received from the 2007 sale of InfoSpherix and the November 2009 stock placement. Over the next 12 months, the Company expects that it will need to expend between $7 million and $9 million to support its development operations.

tagatose, as well as general and administrative costs. Over the next 12 months, the Company expects that it will need to expend between $7 million and $9 million to support its development operations. We will need to raise additional funds in 2010 to continue operations and will likely require additional capital raises thereafter to fully pursue the triglycerides opportunity. We cannot ensure that additional funding will be available or, if it is available, that it can be obtained on terms and conditions we will deem acceptable. Any additional funding derived from the sale of equity securities is likely to result in significant dilution to our existing stockholders. These matters involve risks and uncertainties that may prevent us from raising additional capital or may cause the terms upon which we raise additional capital, if additional capital is available, to be less favorable to us than would otherwise be the case.

WE HAVE SUSTAINED LOSSES IN THE PAST AND WE WILL SUSTAIN LOSSES IN THE FUTURE. We have incurred losses from continuing operations in prior years, including 2009 and 2008. Our net losses from continuing operations before taxes for the years ended December 31, 2009 and 2008 were $9.1 million and $6.2 million, respectively. The Companys cumulative deficit was $30.7 million at June 30, 2010. We expect to incur substantial losses in 2010 and thereafter until we find a purchaser/licensee. The Companys total cash used through the six months ended June 30, 2010 was $4.4 million. We may not return to profitable operations.

THE PRICE OF OUR COMMON STOCK HAS BEEN HIGHLY VOLATILE DUE TO SEVERAL FACTORS THAT WILL CONTINUE TO AFFECT THE PRICE OF OUR STOCK. Our common stock has traded as low as $0.25 and as high as $4.15 between January 1, 2009 and June 30

Read the The complete Report

About the author:

Charlie Tian, Ph.D. - Founder of GuruFocus. You can now order his book Invest Like a Guru on Amazon.

Rating: 4.0/5 (1 vote)


Please leave your comment:

Performances of the stocks mentioned by 10qk

User Generated Screeners

dosowsky1Fast Revenue Growth
Kbannon77All Stocks US
Kbannon77All Stocks
opadovaniP median2
carter2u2Small Cap No Debt
bkw82Predictable/ebitda 10/52 week
pbarker46Hist. High Yield
andrewgu999valleylink - gogogo
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat